Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jcph.511 | DOI Listing |
Nurs Open
October 2024
Western Sydney University, Penrith, New South Wales, Australia.
Aims: This study aimed to describe nurses' experiences caring for patients who use medicinal cannabis. For the purpose of this study, the term 'medicinal cannabis' is used to describe cannabis-based products that are sourced legally or illegally.
Design: Qualitative study using thematic analysis.
Comput Biol Chem
December 2023
Indian Council of Medical Research-National Institute of Traditional Medicine, Belagavi 590010, India.
Delta-9-tetrahydrocannabinol, a component of marijuana, interacts with cannabinoid receptors in brain involved in memory, cognition, and emotional control. However, marijuana use and schizophrenia development is a complicated and contentious topic. As a result, more investigation is needed to understand this relationship.
View Article and Find Full Text PDFTob Control
March 2024
Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Pharmaceuticals (Basel)
May 2023
Advanced Research and Development Center for Experimental Medicine (CEMEX), Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.
The conundrum of 's applications for therapeutical purposes is set apart by the hundreds of known and commercially available strains, the social, cultural and historical context, and the legalization of its use for medical purposes in various jurisdictions around the globe. In an era where targeted therapies are continuously being developed and have become the norm, it is imperative to conduct standardized, controlled studies on strains currently cultivated under Good Manufacturing Practices (GMP) certification, a standard that guarantees the quality requirements for modern medical and therapeutic use. Thus, the aim of our study is to evaluate the acute toxicity of a 15.
View Article and Find Full Text PDFJ Am Assoc Nurse Pract
May 2023
Minnesota State University, Mankato, Minnesota.
The development of anxiety disorders and post-traumatic stress disorder (PTSD) is complex. Both delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are of potential therapeutic use. Evidence suggests that cannabis has a beneficial effect on neural circuitry involved in fear regulation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!